Background: GC has been the standard palliative chemotherapy for patients with advanced biliary tract cancer (BTC). This phase III study aimed to confirm the superiority of GCS to GC in terms of survival in patients with unresectable or recurrent BTC.
No takes yet. Share an insight, caveat, or question.
Sakai et al. (2018) studied this question.